Pharmacodynamic Substances in Promoting Osteogenic Differentiation of Epimedii Folium and Epimedii Wushanensis Folium Based on Chemical Fingerprint-cell Metabolomics Correlation Analysis

HUANG Yunfen; ZHAO Linchao; WU Songnan; XU Fangzhu; GAO Hui; CHEN Xuelian; YUAN Zimin; WANG Jing

doi:10.13422/j.cnki.syfjx.20240869

您当前的位置：

首页 >

文章列表页 >

Pharmacodynamic Substances in Promoting Osteogenic Differentiation of Epimedii Folium and Epimedii Wushanensis Folium Based on Chemical Fingerprint-cell Metabolomics Correlation Analysis

更新时间：2024-07-31

- Pharmacodynamic Substances in Promoting Osteogenic Differentiation of Epimedii Folium and Epimedii Wushanensis Folium Based on Chemical Fingerprint-cell Metabolomics Correlation Analysis
  增强出版
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 17, Pages: 155-163(2024)
- 作者机构：
  
  1.辽宁中医药大学药学院，辽宁大连 116600
  2.山东省妇幼保健院，济南 250000
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20240869
  CLC： R22;R969.1;R28;O657
- Published：05 September 2024，
  
  Published Online：19 April 2024，
  
  Received：23 January 2024，
- 稿件说明：
扫描看全文
黄云芬,赵林超,吴松南等.基于化学指纹-细胞代谢组学相关性分析淫羊藿及巫山淫羊藿促成骨分化的药效物质基础[J].中国实验方剂学杂志,2024,30(17):155-163.

HUANG Yunfen,ZHAO Linchao,WU Songnan,et al.Pharmacodynamic Substances in Promoting Osteogenic Differentiation of Epimedii Folium and Epimedii Wushanensis Folium Based on Chemical Fingerprint-cell Metabolomics Correlation Analysis[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(17):155-163.
黄云芬,赵林超,吴松南等.基于化学指纹-细胞代谢组学相关性分析淫羊藿及巫山淫羊藿促成骨分化的药效物质基础[J].中国实验方剂学杂志,2024,30(17):155-163. DOI： 10.13422/j.cnki.syfjx.20240869.

HUANG Yunfen,ZHAO Linchao,WU Songnan,et al.Pharmacodynamic Substances in Promoting Osteogenic Differentiation of Epimedii Folium and Epimedii Wushanensis Folium Based on Chemical Fingerprint-cell Metabolomics Correlation Analysis[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(17):155-163. DOI： 10.13422/j.cnki.syfjx.20240869.

摘要

目的

确定淫羊藿及巫山淫羊藿促进成骨分化的药效物质基础，并建立一种基于化学指纹与细胞代谢组学相关性分析中药药效物质基础的方法。

方法

采用超高效液相-四极杆-静电场轨道阱高分辨质谱法（UPLC-Q-Exactive Orbitrap-MS）分析4种基原15批淫羊藿和3批巫山淫羊藿药材的化学指纹，通过偏最小二乘法-判别分析（PLS-DA）对不同基原淫羊藿及巫山淫羊藿化学指纹峰面积进行统计学分析；运用细胞增殖与活性检测法（CCK-8）和酶联免疫吸附测定法（ELISA）分别检测淫羊藿及巫山淫羊藿对MC3T3-E1成骨前体细胞增殖活力及成骨细胞碱性磷酸酶（ALP）活性的影响，采用超高效液相色谱-四极杆-飞行时间串联质谱法（UPLC-Q-TOF-MS/MS）分析不同基原淫羊藿及巫山淫羊藿对MC3T3-E1细胞代谢组学的影响。构建细胞代谢组峰表，并引入平均药效作用指标mean

，采用PLS及Pearson相关性分析计算各组mean

和化学指纹的相关性，依据变量重要性投影（VIP）值

1筛选淫羊藿促成骨分化的药效成分，依据各组的mean

评价淫羊藿及巫山淫羊藿的药效作用。

结果

各基原淫羊藿及巫山淫羊藿化学指纹可完全分离。与空白组比较，不同基原淫羊藿及巫山淫羊藿组MC3T3-E1细胞活力均明显增加，淫羊藿（甘肃）、朝鲜淫羊藿、柔毛淫羊藿组均可明显增强MC3T3-E1细胞ALP活性（

0.05）。细胞代谢组学结果显示，空白组与模型组有明显的分离趋势，不同基原淫羊藿及巫山淫羊藿与模型组距离有差异，表明不同基原淫羊藿及巫山淫羊藿促成骨分化作用具有差异。化学指纹-细胞代谢组学整合分析筛选出9个成分与药效关系密切，包括双藿苷B、朝藿定C、淫羊藿苷、宝藿苷Ⅰ、yinyanghuo B、

-脱水淫羊藿素、木兰花碱、隐绿原酸和槲皮素，以朝鲜淫羊藿促成骨分化的药效作用最强。

结论

该研究确定了不同基原淫羊藿及巫山淫羊藿促成骨分化的药效物质基础多为黄酮类、生物碱类和有机酸类成分，为中药药效相关成分筛选及中药疗效预测提供思路与方法。

Abstract

Objective

To determine the pharmacodynamic substance basis of Epimedii Folium（EF）

and Epimedii Wushanensis Folium（EWF）

in promoting osteogenic differentiation， and to establish a method to ana

lyze the material basis of Chinese materia medica based on the correlation between chemical fingerprint and cellular metabolomics.

Method

The chemical fingerprints of 15 batches of EF

with 4 species and

3 batches of EWF

were analyzed by ultra performance liquid chromatography-quadrupole-electrostatic field orbitrap high-resolution mass spectrometry（UPLC-Q-Exactive Orbitrap-MS）， and partial least squares-discriminant analysis（PLS-DA） was used to analyze the peak areas of chemical fingerprints of samples. The effects of different samples on proliferative activity of MC3T3-E1 osteoblast precursors， as well as the activity of alkaline phosphatase（ALP） in osteoblasts were detected by cell counting kit-8（CCK-8） and enzyme-linked immunosorbent assay（ELISA）. At the same time， UPLC-quadrupole-time-of-flight mass spectrometry（UPLC-Q-TOF-MS/MS） was used to analyze the effects of different samples on the metabolomics of MC3T3-E1 cells， then metabolic peak table of osteogenic differentiation cells was constructed， and pharmacodynamic index mean

was introduced into the peak table. PLS was used to calculate mean

of each group， and the mean

was added to the peak table of chemical fingerprint to construct the correlation between chemical fingerprint and cell metabolome， the pharmacodynamic components of EF and EWF that promote bone differentiation were screened according to variable importance in the projection（VIP） value

1. The pharmacodynamic effects of EF and EWF were evaluated according to the mean

of each group.

Result

The chemical fingerprints of EF with different origins and EWF

were completely separated. Compared with the blank group， the activity of MC3T3-E1 cells in EF and EWF

groups was significantly increased， the activity of ALP in the

Epimedium

brevicornu

（Gansu province），

koreanum

and

pubescens

groups was significantly increased（

0.05）. The results of cell metabolomics showed that the blank group and the model group had an obvious trend of separation. EF with different origins and EWF had different distance from the model group， indicating that EF with different origins and EWF had different effect on promoting osteogenic differentiation. Chemical fingerprint-cell metabolomics integration analysis screened 9 components closely related to the efficacy of EF and EWF， including

diphylloside B， epimedin C， icariin， baohuoside Ⅰ， yinyanghuo B，

-anhydroicaritin， magnoflorine， cryptochlorogenic acid and quercetin.

E. koreanum

had the strongest effect on promoting osteogenic differentiation.

Conclusion

This study determined that the material basis of EF and EWF promoting osteogenic differentiation were mostly flavonoids， alkaloids and organic acids， which provided ideas and methods for the screening of pharmacodynamic components and the prediction of therapeutic effect of Chinese materia medica.

关键词

淫羊藿巫山淫羊藿药效物质基础细胞代谢组学化学指纹促成骨分化超高效液相-四极杆-静电场轨道阱高分辨质谱法（UPLC-Q-Exactive Orbitrap-MS）

Keywords

Epimedii FoliumEpimedii Wushanensis Foliumpharmacodynamic substancescell metabolomicschemical fingerprintpromoting osteogenic differentiationultra performance liquid chromatography-quadrupole-electrostatic field orbitrap high-resolution mass spectrometry（UPLC-Q-Exactive Orbitrap-MS）

references

国家药典委员会.中华人民共和国药典：一部［M］.北京：中国医药科技出版社，2020：340-342.

刘鑫，何小英，刘柏龙，等.UPLC结合一测多评法测定药典中淫羊藿的13种化学成分［J］.中国中药杂志，2024，49（4）：981-988.

李莉，王嘉瑞，王晶，等.淫羊藿的主要化学成分、药理作用研究进展及质量标志物的预测分析［J］.中华中医药学刊，2023，41（11）：143-151.

边帅杰，康忠禹，赵大庆，等.基于UHPLC-Q Exactive Orbitrap/MS结合多元统计方法分析不同基原淫羊藿化学成分的差异［J］.中药材，2024，47（1）：106-110.

周晓洁，姚辛敏，周妍妍.淫羊藿的药理作用研究进展［J］.中医药学报，2022，50（11）：112-115.

LIM R Z L，LI L，YONG E L，et al.STAT-3 regulation of CXCR4 is necessary for the prenylflavonoid icaritin to enhance mesenchymal stem cell proliferation，migration and osteogenic differentiation［J］.Biochim Biophys Acta Gen Subj，2018，1862（7）：1680-1692.

LIU H ，XIONG Y ，WANG H，et al.Effects of water extract from Epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model［J］.J Ethnopharmacol，2018，221：126-136.

张正，陈江平，程学仁，等.淫羊藿配方颗粒UPLC特征图谱及主要成分含量测定研究［J］.中医药导报，2020，26（14）：20-23，28.

LI H F，GUAN X Y，YANG W Z，et al.Antioxidant flavonoids from Epimedium wushanense［J］.Fitoterapia，2012，83（1）：44-48.

司玉芳，严少普，王文博.淫羊藿苷改善中枢神经系统疾病的研究进展［J］．现代药物与临床，2023，38（4）：988-994.

谢娟平，谢人明，王小微.巫山淫羊藿主要成分朝藿定C和双藿苷A抗炎作用研究［J］.中国现代应用药学，2012，29（3）：198-201.

HU L，XIE X，XUE H，et al.MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2［J］.Exp Mol Med，2022，54（7）：961-972.

夏维波，余卫，王以朋，等.原发性骨质疏松症社区诊疗指导原则［J］.中国全科医学，2019，22（10）：1125-1132.

RIVADENEIRA F，MÄKITIE.O.Osteoporosis and bone mass disorders：From dene pathways to treatments［J］.Trends Endocrinol Metab，2016，27（5）：262-281.

周雅婷，刘颖，毕亚男，等.淫羊藿水提物及提取药渣的抗骨质疏松药效比较研究［J］.天津中医药大学学报，2020，39（1）：87-91.

李天娇，于洋，王帅，等.仙灵脾颗粒体外抗骨质疏松作用及谱效关系研究［J］.时珍国医国药，2023，34（7）：1573-1576.

徐众华，莫雨晴，周驰.基于BMP/Runx2/Osx信号通路研究淫羊藿总黄酮改善绝经后骨质疏松模型大鼠的作用机制［J］.中国药房，2020，31（19）：2333-2338.

毛玉芝，曾敬其，杨冰，等.淫羊藿黄酮低糖苷组分对维甲酸致骨质疏松大鼠的疗效及作用机制［J］.中国中药杂志，2022，47（16）：4446-4453.

金垚，徐鹏辉，卞泗善，等.淫羊藿苷调节PTEN激活成骨基因表达缓解大鼠骨质疏松症的实验研究［J］.中医药信息，2023，40（6）：38-43，53.

徐忠坤，殷洪梅，李芳，等.淫羊藿总黄酮胶囊中黄酮类成分含量测定及抗骨质疏松活性研究［J］.中国中药杂志，2018，43（15）：3140-3144.

徐杨，何芷绮，刘晓凤，等.代谢组学在中药复方制剂领域的研究进展及面临的挑战［J］.中草药，2024，55（4）：1354-1364.

刘姬艳，胡定慧，胡芳华，等.淫羊藿总黄酮对血管生成抑制作用的初步研究［J］.杭州师范大学学报：自然科学版，2014，13（3）：304-306.

姜涛.基于ERα/AMPK/Sirt1信号通路探讨PMOP的发病机制及淫羊藿苷的干预［D］.广州：广州中医药大学，2020.

付殷，刘宇洲，胡晓阳，等.基于铁死亡通路研究淫羊藿苷对大鼠成骨细胞增殖分化的影响［J］.时珍国医国药，2022，33（9）：2100-2103.

杨冰璇，姜涛，贾敏，等.淫羊藿苷增强自噬促进小鼠前成骨细胞的分化［J］.中国组织工程研究，2022，26（1）：64-69.

岳峥嵘，张悦，汤建成，等.淫羊藿苷经PI3K/Akt/mTOR通路调控激素对骨微血内皮细胞自噬的影响［J］.中国实验方剂学杂志，2024，30（15）：73-80.

XIA Y H，JIANG T W，YU J M，et al.Preliminary studies on the anti-osteoporosis activity of baohuoside I ［J］.Biomed Pharmacother，2019 （115）：108850.

SATUÉ M，ARRIERO，M D，et al.Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW264.7 cells［J］.Biochem Pharmacol，2013，86（10）：1476-1486.

宋鹏，姚娟，马慧萍，等.脱水淫羊藿素与山柰素对体外培养成骨细胞成熟矿化影响的比较研究［J］.药学学报，2012，47（7）：890-896.

YU L，JIN Y，SONG M，et al.When natural compounds meet nanotechnology：Nature-inspired nanomedicines for cancer immunotherapy［J］.Pharmaceutics，2022，14 （8）：1589.

张双庆，孙丽翠，黄振武.大鼠体内淫羊藿素葡萄糖醛酸代谢物的定量研究［J］.卫生研究，2015，44（1）：91-94.

KIM K M，KIM T H，JANG W G.Effect of cryptochlorogenic acid extracted from fruits of Sorbus commixta on osteoblast differentiation［J］.J Korean Soc Food Sci Nutr，2017，46（3）：314-319.

HUNG T M，NA M，MIN B S，et al.Protective effect of magnoflorine isolated from Coptidis Rhizoma on Cu2+-induced oxidation of human low density lipoprotein［J］.Planta Med，2007，73（12）：1281-1284.

SUN Z，ZENG J，WANG W，et al.Magnoflorine suppresses MAPK and NF-κB signaling to prevent inflammatory osteolysis induced by titanium particles in vivo and osteoclastogenesis via RANKL in vitro［J］.Front Pharmacol，2020，11：389.

成丽媛，霍香香，杨莉，等.UPLC法测定不同基源淫羊藿中11种有效成分的含量［J］.天津中医药大学学报，2022，41（2）：237-242.

毕肖林，马世堂，狄留庆，等.中药药效物质筛选与辨识的研究思路及进展［J］.中草药，2018，49（22）：5229-5234.

李建锋，荀丽英，李航，等.中药成分的生物学活性评价及筛选［J］.中草药，2015，46（4）：588-594.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of Chemical Components and Tissue Distribution of Lujiao Formula Based on UPLC-Q-Orbitrap-MS

Screening Effective Sites of Momordicae Semen-Epimedii Folium and Anti-lung Cancer Mechanism of Its Prescription

Mechanism of Epimedii Folium in Treatment of Oligoasthenotspermia Based on Network Pharmacology and Molecular Docking

Active Constituents and Mechanism of Epimedii Folium Against Liver Cancer： A Review

Related Author

ZHANG Jianwei

LIU Wei

SHEN Qin

LIU Li

ZANG Yuanlong

LI Jun

ZENG Rui

CUI Xihe

Related Institution

Third Grade Laboratory of Traditional Chinese Medicine（TCM） Preparations， National Administration of TCM，Shuguang Hospital Affiliated to Shanghai University of TCM

School of Chinese Materia Medicine,Beijing University of Chinese Medica

Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences

Anhui University of Chinese Medicine

Tea Research Institute， Sichuan Academy of Agricultural Sciences

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰